作者
Reina N. Fuji,Michael Flagella,Miriam Baca,Marco A. S. Baptista,Jens Brodbeck,Bryan Chan,Brian Fiske,Lee Honigberg,Adrian M. Jubb,Paula Katavolos,Donna W. Lee,Sock-Cheng Lewin-Koh,Tori Lin,Xingrong Liu,Shannon Liu,Joseph P. Lyssikatos,Jennifer O’Mahony,Mike Reichelt,Merone Roose‐Girma,Zejuan Sheng,Todd Sherer,Ashley Smith,Margaret Solon,Zachary K. Sweeney,Jacqueline M. Tarrant,Alison Urkowitz,Søren Warming,Murat Yaylaoglu,Shuo Zhang,Haitao Zhu,Anthony A. Estrada,Ryan J. Watts
摘要
LRRK2 kinase inhibitors, under development for Parkinson’s disease, have an effect on type II pneumocytes in nonhuman primate lung, suggesting that pulmonary toxicity may be a critical safety liability.
有人
寻道图强
AireenBeryl531
浅尝离白
JY
Singularity
清脆松
8R60d8
tuanheqi
华仔
Ava
美好乐松
研友_ZAVbe8
paparazzi221
传奇3
shinysparrow
西罗
良辰
鬼见愁
lanxinyue
皖公网安备34019202002308
